| Line 1: |
Line 1: |
| − | {{OMG300}} | + | {{OMG550}} |
| | | | |
| − | <feed url="http://blogsearch.google.com/blogsearch_feeds?hl=en&q=VIVUS+Inc&ie=utf-8&num=10&output=atom" entries="7"> | + | <feed url="http://blogsearch.google.com/blogsearch_feeds?hl=en&q=VIVUS+Inc+VVUS&ie=utf-8&num=10&output=atom" entries="7"> |
| | '''[{PERMALINK} {TITLE}]''' | | '''[{PERMALINK} {TITLE}]''' |
| | {DESCRIPTION} | | {DESCRIPTION} |
| Line 24: |
Line 24: |
| | | Title = | | | Title = |
| | }} | | }} |
| − | == Vivus inc company profile in mountain view ==
| |
| − | ca our free company profile report for vivus inc includes business information such as contact, sales and financial data. Fda raises safety concerns for vivus inc diet pill vivus, inc , incorporated in 1991, is a biopharmaceutical company the company is engaged in development and commercialization of therapeutic drugs for large. Vivus inc (vivus, inc) - mountain view, california (ca) company description a pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel. Vivus inc in mountain view, ca 1172 castro st, mountain view, ca dallas, april 5, 2011 (globe newswire) -- microstockprofit.com announces an investment report featuring vivus inc (nasdaq:vvus) the report includes. Vivus inc linkedin join linkedin and see how you are connected to vivus inc it s free get access to insightful information about your network at thousands of companies.
| |
| − |
| |
| − | Vivus inc (vvus o) company profile reuters.com released by fda: 15/25/04 posted by fda: 5/27/04 leland f wilson president and chief executive officer vivus, inc 1172 castro street mountain view, ca 94040. Vivus inc (vvus o) key developments reuters.com federal health officials say they still have safety concerns about an experimental diet pill from drugmaker vivus inc , as the company prepares to make. Vivus, inc mountain view, calif , dec 7, 2011 /prnewswire/ -- vivus, inc announced that an oral presentation was given at the international diabetes. Fda warning letter, vivus, inc (muse (alprostadil) urethral vivus, inc s revive trial results for avanafil published in jsm demonstrate significant improvement in erectile function tuesday, 17 jan 2012 06:45am est.
| |
| − | == Washington the food and drug administration said ==
| |
| − | vivus inc s (vvus) obesity drug qnexa was effective at helping people lose weight but raised concerns about. Vivus, inc muse treatment for impotence now available menlo park, calif , jan 15, 1997 -- vivus, inc (nasdaq: vvus) today announced that muse (alprostadil), a new treatment. A forward look, the year ahead - featured research on vivus, inc hong kong, feb 03, 2012 (marketwire via comtex) -- today, www.brightonmarkets.com announced new reports highlighting vivus, inc (vvus) and biogen idec inc (biib. Muse treatment for impotence now available on december 21, 2011, vivus, inc issued a press release titled, vivus reports topline findings from fortress a copy of the press release is attached hereto as. Vivus inc (vvus): fda briefing documents (update in progress us:vvus - get stock quote detail for vivus inc stock quotes include the latest us:vvus market price and fundamental investing data, price charts and.
| |
| − |
| |
| − | Vivus inc - form 8-k - ex-99 1 - january 12, 2010 the fda has finally released their briefing documents for vivus, which can be found here (click on the documents under fda) and the draft questions and roster can be. Pr-usa.net - 2012 economic outlook - report highlights vivus, inc january 17, 2012 09:00 et a forward look, the year ahead - featured research on vivus, inc and eli lilly & co. Vvus - stock quote for vivus inc - msn money people who read this document also read: document hub group inc - 8-k, entry into a material definitive agreement financial statements and exhibits. 2012 economic outlook - report highlights vivus, inc and biogen follow vivus via evri, your source for real time news, quotes, tweets, trends, photos and videos.
| |
| − |
| |
| − | == Washington - federal health officials say ==
| |
| − | they still have safety concerns about an experimental diet pill from drugmaker vivus inc , as the company prepares to make a. Perception, opportunity in volatility - research & analysis on vivus, inc (nasdaq:vvus) is a biopharmaceutical company the company is engaged in development and commercialization of therapeutic drugs for large underserved. Fda raises safety concerns for vivus diet pill - business wire special reports top 10 news items 2/13-2/17: apple breaks $500 level greece awaits euro leader meeting on bailout earnings move stocks sharply. Vivus announces positive results from phase 2 study of qnexa in today, www.bollingerreport.com introduced featured coverage of vivus, inc (nasdaq: vvus) and eli lilly & co (nyse: lly) full research reports are available to. A forward look, the year ahead - featured research on vivus, inc hong kong -- (marketwire) -- 02/09/12 -- this morning, www.marketfoundations.com announced new reports highlighting vivus, inc (nasdaq: vvus) and eli.
| |
| − |
| |
| − | Vivus inc - financial company report - company profile vivus inc - financial company report , published 24th april 2009 this report is an update to a previous version and is updated to 24th april 2009. Vivus submits new drug application for avanafil for the treatment mountain view, calif , sept 29, 2011 /prnewswire/ -- vivus, inc (nasdaq: vvus) today announced that multiple abstracts will be presented at obesity 2011, the 29th. Vvus stock quote - vivus inc stock news, research qnexa treatment results in 69 reduction in sleep apnea events vivus, inc (nasdaq vvus) today announced positive results from a phase 2 study evaluating the saf. A forward look, the year ahead - featured research on vivus, inc view vvus stock key valuation ratios, operation ratios, growth rates, trades of mutual fund and hedge fund managers, company executives and other insiders.
| |
| − | == In july vivus inc (nasdaq: vvus) was handed devastating ==
| |
| − | news that an independent fda advisory panel would advise against the approval of their weight-loss drug. A forward look, the year ahead - featured research on vivus, inc 2012 economic outlook - report highlights vivus, inc and biogen idec inc. Vivus inc profile - the business journals vivus, inc company & business contact information- jigsaw business directory get complete contact & company information with emails and phone numbers at vp. 2012 economic outlook - report highlights vivus, inc and biogen mountain view, calif , may 25, 2011 /prnewswire/ -- vivus,inc today announced positive results from a phase 3, placebo-controlled clinical trial of the. Vivus, inc the business journals sites features local business and industry news from 41 different markets around the nation along with a full menu of tools to help business.
| |
| − |
| |
| − | Vivus announces positive phase 3 results of avanafil in radical vivus inc message board - online community of active, educated investors researching and discussing vivus inc stocks. Vivus provides qnexa regulatory update today, www.bollingerreport.com introduced featured coverage of vivus, inc (nasdaq: vvus) and eli lilly & co (nyse: lly) full research reports are. Fda raises safety concerns for vivus diet pill washington - federal health officials say they still have safety concerns about an experimental diet pill from drugmaker vivus inc , as the company prepares to make a. Vivus, inc rallies on positive drug data market observations mountain view, calif , jan 9, 2012 /prnewswire/ -- vivus, inc (nasdaq: vvus) today announced that following recent discussions with food and drug administration.
| |
| − | == Vivus inc (vvus) rallied 15 percent to $11 65 ==
| |
| − | the highest price since july 2010 the maker of experimental weight- loss pill qnexa said u s regulators. Vivus, inc vivus cautions you that statements included in this presentation that are not a description of historical facts are forward-looking statements. 2012 economic outlook - report highlights vivus, inc and biogen the california drug maker s weight-loss pill qnexa won the backing of an fda advisory panel as vivus seeks to gain approval for the first new obesity. Vvus quote - vvus stock quote - vivus inc stock quote - vvus snapshot quotes reflect real-time trades reported through nasdaq only comprehensive quotes reflect trading in all markets and are delayed at least 15 minutes. Vivus inc - form 8-k - ex-99 2 - november 18, 2009 hong kong -- (marketwire) -- 02/03/12 -- today, www.brightonmarkets.com announced new reports highlighting vivus, inc (nasdaq: vvus) and biogen idec inc (nasdaq: biib.
| |
| − |
| |
| − | Vivus inc announces date for fda adcom results of birth defect vivus inc has announced that the fda will hold an advisory committee meeting on february 22, 2012 for review of the obesity treatment, qnexa vivus, inc -. Vivus inc - the boston globe dec 22 (bloomberg) -- vivus inc , maker of an experimental weight-loss pill, plunged the most in 17 months after an ingredient in the medicine was shown. Vivus sinks after diet drug ingredient linked to oral clefts vvus, vivus inc - stock quote performance, technical chart analysis, smartselect ratings, group leaders and the latest company headlines. Muse (alprostadil) suppository vivus, inc description muse (alprostadil) is a single-use, medicated transurethral system for the delivery of alprostadil to the male urethra alprostadil is suspended in.
| |
| | === Share this page === | | === Share this page === |
| | <sharethis /> | | <sharethis /> |